Cosmo Pharmaceuticals announces worldwide exclusive
Distribution Agreement for Eleview® with Medtronic
Dublin, December 2, 2019 - Cosmo Pharmaceuticals NV (SIX: COPN) announced today that it has entered into a new worldwide supply and distribution agreement for Eleview® with Medtronic (with the exception of Japan and Canada, licensed respectively to EA Pharma and Pendopharm), having in the meantime terminated by mutual consent the co-marketing agreement with Fujifilm.
"This deal further strengthens our cooperation with Medtronic and allows the Eleview® franchise to expand on a global scale. We are looking forward to making Eleview® a worldwide success", said Alessandro Della Chà, CEO of Cosmo.
Provider | Channel | Contact | ||
---|---|---|---|---|
EQS Group Ltd., Switzerland switzerland.eqs.com |
newsbox.ch www.newsbox.ch |
Provider/Channel related enquiries cs.switzerland@eqs.com +41 41 763 00 50 |